FFCP PHASE1:Mm9::chr16:19236435..19236445,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=18|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr16:19236435..19236445,+|id=chr16:19236435..19236445,+|ontology_enrichment_celltype=CL:0000553!4.73e-12!6;CL:0000556!4.73e-12!6;CL:0000050!4.68e-08!9|ontology_enrichment_celltype_v019_2=CL:0000553,6.22e-30,6;CL:0000556,6.22e-30,6;CL:0000050,3.75e-20,9;CL:0000839,4.15e-14,13;CL:0000945,7.11e-12,1;CL:0000236,7.11e-12,1;CL:0000826,7.11e-12,1;CL:0000763,1.51e-11,16;CL:0002031,3.05e-11,25;CL:0000049,8.68e-10,19;CL:0000988,7.98e-09,32;CL:0002032,7.98e-09,32;CL:0000037,7.98e-09,32;CL:0000837,7.98e-09,32|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002193!3.32e-07!48|ontology_enrichment_uberon_v019_2=UBERON:0000029,2.59e-12,1;UBERON:0001097,2.59e-12,1;UBERON:0003968,2.59e-12,1;UBERON:0001467,2.59e-12,1;UBERON:0002371,1.51e-11,16;UBERON:0001474,1.67e-08,22;UBERON:0004765,1.67e-08,22;UBERON:0001434,1.67e-08,22;UBERON:0002193,2.27e-08,48;UBERON:0002405,2.27e-08,48|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.61980213911861,0,7.88655413395594,8.08975158273859,7.21462408056651,0,0,0,0.799962113967033,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.17447824240415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,6.47344709117929,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0.510914110417183,0,0,0,0,0,0,0,0,0,0,0,0.373220911830279,0,0.420883711772948,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.554259570499814,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0.518054945597687,0,0,0,0,0.275936746304732,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32745138339963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.22132145037209,0,0,0,0.546776910884101,0.457556346413045,0,0,0,0,0,0,0,0,0,0,0,0,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr16:19236435..19236445,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=18 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr16:19236435..19236445,+ | |||
|description=CAGE_peak_at_chr16:19236435..19236445,+ | |||
|id=chr16:19236435..19236445,+ | |||
|ontology_enrichment_celltype=CL:0000553!4.73e-12!6;CL:0000556!4.73e-12!6;CL:0000050!4.68e-08!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,6.22e-30,6;CL:0000556,6.22e-30,6;CL:0000050,3.75e-20,9;CL:0000839,4.15e-14,13;CL:0000945,7.11e-12,1;CL:0000236,7.11e-12,1;CL:0000826,7.11e-12,1;CL:0000763,1.51e-11,16;CL:0002031,3.05e-11,25;CL:0000049,8.68e-10,19;CL:0000988,7.98e-09,32;CL:0002032,7.98e-09,32;CL:0000037,7.98e-09,32;CL:0000837,7.98e-09,32 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002193!3.32e-07!48 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000029,2.59e-12,1;UBERON:0001097,2.59e-12,1;UBERON:0003968,2.59e-12,1;UBERON:0001467,2.59e-12,1;UBERON:0002371,1.51e-11,16;UBERON:0001474,1.67e-08,22;UBERON:0004765,1.67e-08,22;UBERON:0001434,1.67e-08,22;UBERON:0002193,2.27e-08,48;UBERON:0002405,2.27e-08,48 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.61980213911861,0,7.88655413395594,8.08975158273859,7.21462408056651,0,0,0,0.799962113967033,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.17447824240415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,6.47344709117929,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0.510914110417183,0,0,0,0,0,0,0,0,0,0,0,0.373220911830279,0,0.420883711772948,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.554259570499814,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0.518054945597687,0,0,0,0,0.275936746304732,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32745138339963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.22132145037209,0,0,0,0.546776910884101,0.457556346413045,0,0,0,0,0,0,0,0,0,0,0,0,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr16:19236435..19236445,+ | |||
}} |
Latest revision as of 03:32, 6 August 2015
Short description: | p@chr16:19236435..19236445, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr16:19236435..19236445, + |
Coexpression cluster: | MCL_coexpression_mm9:18 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 6.22e-30 | 6 |
megakaryocyte | 6.22e-30 | 6 |
megakaryocyte-erythroid progenitor cell | 3.75e-20 | 9 |
myeloid lineage restricted progenitor cell | 4.15e-14 | 13 |
lymphocyte of B lineage | 7.11e-12 | 1 |
B cell | 7.11e-12 | 1 |
pro-B cell | 7.11e-12 | 1 |
myeloid cell | 1.51e-11 | 16 |
hematopoietic lineage restricted progenitor cell | 3.05e-11 | 25 |
common myeloid progenitor | 8.68e-10 | 19 |
hematopoietic cell | 7.98e-09 | 32 |
hematopoietic oligopotent progenitor cell | 7.98e-09 | 32 |
hematopoietic stem cell | 7.98e-09 | 32 |
hematopoietic multipotent progenitor cell | 7.98e-09 | 32 |
Ontology term | p-value | n |
---|---|---|
lymph node | 2.59e-12 | 1 |
axillary lymph node | 2.59e-12 | 1 |
peripheral lymph node | 2.59e-12 | 1 |
shoulder | 2.59e-12 | 1 |
bone marrow | 1.51e-11 | 16 |
bone element | 1.67e-08 | 22 |
skeletal element | 1.67e-08 | 22 |
skeletal system | 1.67e-08 | 22 |
hemolymphoid system | 2.27e-08 | 48 |
immune system | 2.27e-08 | 48 |